These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17434154)

  • 21. Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.
    Townsley E; Woda M; Thomas SJ; Kalayanarooj S; Gibbons RV; Nisalak A; Srikiatkhachorn A; Green S; Stephens HA; Rothman AL; Mathew A
    Immunology; 2014 Jan; 141(1):27-38. PubMed ID: 23941420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus.
    Sabetian S; Nezafat N; Dorosti H; Zarei M; Ghasemi Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2546-2563. PubMed ID: 30035699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of highly conserved, serotype-specific dengue virus sequences: implications for vaccine design.
    Chong LC; Khan AM
    BMC Genomics; 2019 Dec; 20(Suppl 9):921. PubMed ID: 31874646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Neutralizing Dengue Virus B Cell Epitopes and Protective T Cell Epitopes With Those in Three Main Dengue Virus Vaccines.
    Pinheiro JR; Camilo Dos Reis E; Souza RDSO; Rocha ALS; Suesdek L; Azevedo V; Tiwari S; Rocha BGS; Birbrair A; Méndez EC; Luiz WB; Amorim JH
    Front Immunol; 2021; 12():715136. PubMed ID: 34489965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of B cell epitopes of dengue virus 2 NS3 protein by monoclonal antibody.
    Tian Y; Chen W; Yang Y; Xu X; Zhang J; Wang J; Xiao L; Chen Z
    Appl Microbiol Biotechnol; 2013 Feb; 97(4):1553-60. PubMed ID: 23081772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection.
    Mathew A; Kurane I; Green S; Stephens HA; Vaughn DW; Kalayanarooj S; Suntayakorn S; Chandanayingyong D; Ennis FA; Rothman AL
    J Virol; 1998 May; 72(5):3999-4004. PubMed ID: 9557687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2.
    Duan ZL; Liu HF; Huang X; Wang SN; Yang JL; Chen XY; Li DZ; Zhong XZ; Chen BK; Wen JS
    Virus Res; 2015 Jan; 196():5-12. PubMed ID: 25449574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes.
    Piazza P; Campbell D; Marques E; Hildebrand WH; Buchli R; Mailliard R; Rinaldo CR
    Clin Exp Immunol; 2014 Sep; 177(3):696-702. PubMed ID: 24816171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of multiple cytotoxic T lymphocyte responses in mice by a multiepitope DNA vaccine against dengue virus serotype 1.
    Chen XY; Li Z; Zhong XZ; Chen B; Duan ZL; Wen JS
    Microbiol Immunol; 2016 Dec; 60(12):835-845. PubMed ID: 27981613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.
    Prabdial-Sing N; Puren AJ; Bowyer SM
    BMC Immunol; 2012 Dec; 13():67. PubMed ID: 23227878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of peptide selection approaches for epitope-based vaccine design.
    Schubert B; Lund O; Nielsen M
    Tissue Antigens; 2013 Oct; 82(4):243-51. PubMed ID: 24461003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
    Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
    Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale analysis of antigenic diversity of T-cell epitopes in dengue virus.
    Khan AM; Heiny AT; Lee KX; Srinivasan KN; Tan TW; August JT; Brusic V
    BMC Bioinformatics; 2006 Dec; 7 Suppl 5(Suppl 5):S4. PubMed ID: 17254309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.
    Huang X; Karabudak A; Comber JD; Philip M; Morcol T; Philip R
    Hum Vaccin Immunother; 2017 Nov; 13(11):2612-2625. PubMed ID: 28933657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates.
    Sabah SN; Gazi MA; Sthity RA; Husain AB; Quyyum SA; Rahman M; Islam MR
    Interdiscip Sci; 2018 Jun; 10(2):251-260. PubMed ID: 27640170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
    Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
    J Virol; 2020 May; 94(10):. PubMed ID: 32132233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.
    Rivino L; Kumaran EA; Jovanovic V; Nadua K; Teo EW; Pang SW; Teo GH; Gan VC; Lye DC; Leo YS; Hanson BJ; Smith KG; Bertoletti A; Kemeny DM; MacAry PA
    J Virol; 2013 Mar; 87(5):2693-706. PubMed ID: 23255803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design.
    Hussain M; Idrees M; Afzal S
    Curr Comput Aided Drug Des; 2015; 11(1):84-97. PubMed ID: 26022067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.